Skip to main content
Premium Trial:

Request an Annual Quote

MD Anderson to Use Sequenom Systems for Epigenomic and Genotyping Research

NEW YORK, Feb. 6 (GenomeWeb News) - The MD Anderson Kleberg Center for Molecular Markers at the University of Texas has purchased Sequenom's MassArray genetic analysis system and iPlex assay, Sequenom said today.

 

The technology will be used for the center's molecular marker research and individualized cancer case initiatives, according to a statement. Researchers at the center will use the systems to identify individuals at high risk for developing specific types of cancer, develop screeing approaches for early diagnosis of cancer, and "tailor therapy to the genetic make-up of each patient."

 

Financial details were not provided.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more